Category

Clinical Trials

Oncolytic adenovirus

First patient dosed in TILT Biotherapeutics’ Phase I trial

May 5, 2021

The company has progressed to …

Ravi Rao

First patient dosed in Sobi’s XTEND-Kids study

May 4, 2021

Swedish Orphan Biovitrum has announced …

Martin Holst Lange

Novo Nordisk initiates phase 3a development with oral semaglutide

May 4, 2021

Novo Nordisk has announced the …

Francois Martelet

Green light for Oasmia’s phase 1b Docetaxel Micellar trial

April 26, 2021

Oasmia Pharmaceutical has announced that …

Mount Sinai

RhoVac adds prestigious hospital to its Phase IIb trial

April 23, 2021

RhoVac has announced that Mount …

Lundbeck Research

Lundbeck continues brexpiprazole trial

April 21, 2021

Lundbeck and Otsuka announce decision …

Martin Holst Lange

Novo Nordisk expands collaboration with Gilead

April 20, 2021

Gilead Sciences and Novo Nordisk …

Martin Jönsson

AlzeCure announces positive data

April 20, 2021

AlzeCure Pharma has received positive …

Lone Simonsen

New research project on Nordic health data

April 19, 2021

A new Nordic research project …

New data from BioArctic and Eisai

April 6, 2021

The companies have announced data …

Thomas Olin

Promising preclinical results from Kancera

March 26, 2021

The research results show that …

lab

Preclinical study results from Follicum

March 24, 2021

Follicum announces that significant progress …

Outi Vaarala

Orion and Bayer expand development program

March 10, 2021

Orion Corporation and Bayer are …

Annette Säfholm

Gedea adds three Swedish clinics to its ongoing study

March 10, 2021

Gedea Biotech has added three …

renal cancer

The Swedish Medical Products Agency approves Oncorena’s Phase 1/2 trial

March 2, 2021

Oncorena has announced the Swedish …

Anna Hill

First child vaccinated in Scandinavian Biopharma’s Phase IIb Gambia trial

March 1, 2021

The first child has been …

1
2
3
···
35